• Users Online: 775
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2017  |  Volume : 7  |  Issue : 3  |  Page : 113-114

Carcinosarcoma of the Breast: A retrospective observational study

Department of Radiotherapy, VMMC and Safdarjung Hospital, New Delhi, India

Correspondence Address:
Deepti Sharma
Room No 271, Second Floor, New OPD Block, VMMC and Safdarjung Hospital, New Delhi - 110 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/AIHB.AIHB_12_17

Rights and Permissions

Background: Carcinosarcoma of the breast is an extremely rare breast condition, accounting for 0.1% of all breast malignancies. Limited data are available in English literature on this issue due to paucity of cases. Hence, we retrieved data of carcinosarcoma of breast for evaluation of clinicopathological characteristics, treatment, and outcome of this emerging issue. Materials and Methods: A retrospective observational study was conducted from January 2011 to December 2015 in our Department of Radiotherapy. A total of four patients were identified during this period for analysis in this study. Various parameters such as age, clinical features, clinical stage, and the treatment received by the patients were recorded and analyzed for outcome. Results and Discussion: Median age at the time of presentation was 42 years (range 28–46 years). Seventy five percent females were post-menopausal. The most common symptom was slowly growing lump in the breast. All of the patients, except one, were negative for oestrogen receptor/progesterone receptor (ER/PR) and human epidermal growth factor receptor 2 (HER2/neu) receptors. All patients underwent surgery followed by adjuvant therapy,except one. Median follow-up was 23 months (range 2–66 months). Conclusion: Carcinosarcoma of the breast is a rare entity with poor outcome. There are no specific treatment guidelines. Surgery is the main treatment modality, and it should be followed by adjuvant chemo and radiotherapy.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded343    
    Comments [Add]    

Recommend this journal